Methods and compositions for treatment of diabetes mellitus, hyp

Details Methods and compositions for treatment of diabetes mellitus, hyp Methods and compositions for treatment of diabetes mellitus, hyp

1991-10-10

1994-06-14

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 21, A61K 3726, A61K 3702

Patent

active

053210085

ABSTRACT:
Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.

REFERENCES:
patent: 4434159 (1984-02-01), Sekine et al.
Azria et al., "Calcitonins--Physiological and Pharmacological Aspects," pp. 1-34, Springer-Verlag (1989).
BioWorld Today, vol. 2, No. 125 (1991).
Evans et al., Lancet 1:280 (1978) (cited in the application on p. 23).
Passariello et al., J. Clinical Endocrinology and Metabolism 53:318-23 (1981) (cited in the application on p. 23).
Blahos et al., Endokrinologie, Band 68, Heft 2, 226-30, (1976).
Gattereau et al., J. Clinical Endocrinology and Metabolism 51:354-57 (1980).
Giugliano, Biomedicine & Pharmacotherapy 38:273-77 (1984).
Giugliano et al., Am. J. Physiol. 242:E206-13 (1982).
Giugliano et al., Diabete & Metabolisme 8:213-16 (1982).
Giustina et al., J. Endocrinol. Invest. 8:19-23 (1985).
Lunetta et al., J. Endocrinol. Invest. 4: 185-88 (1981).
MacIntyre, Regulatory Peptides 34:81 (1991); Passeri et al.
G. Clin. Med. 55:362-70 (1973); Sgambato et al.
Acta Diabet. Lat. 18:235-41 (1981).
Starke et al., Diabetologic 20:547-52 (1981).
Zofkova et al., Exp. Clin. Endocrinol. 89:91-96 (1987).
Zofkova et al., Horm. Metabol. Res. 19:655-60 (1987).
Zofkova, Acta. Univ. Carol. Med. 32:319-25 (1986).
Ferlito et al., Il Farmaco-Ed. Pr.-vol. 37-fasc. 7:239-44 (1982).
Zamrazil et al., Horm. Metab. Res. 13:631-35 (1981).
Yamaguchi et al., Diabetes 39:168-74 (1990).
Stracca et al., Calcitonin 1984; Yamaguchi, Chem. Pharm. Bull. 29:1455-58 (1981).
Yamaguchi, Endocrinol. Japon. 28:643-46 (1981).
Yamaguchi, Endocrinol. Japon. 28:51-57 (1980).
Yamaguchi et al., Chem. Pharm. Bull. 25:2189-94 (1977).
Ziegler et al., Horm. Metab. Res. 4:60 (1972).

Affiliated with

Also associated with

Rating

Methods and compositions for treatment of diabetes mellitus, hyp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treatment of diabetes mellitus, hyp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treatment of diabetes mellitus, hyp will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1249275